Scientific advice for high-risk medical devices
Submitted by Anonymous (not verified) on 29 May 2026 - 10:17
Scientific advice for high-risk medical devices
Concept paper on the need for revision of the guideline on the development of medicinal products for the treatment of smoking
Submitted by Anonymous (not verified) on 29 May 2026 - 9:34
Concept paper on the need for revision of the guideline on the development of medicinal products for the treatment of smoking
Quality of medicines: questions and answers - Part 2
Submitted by Anonymous (not verified) on 29 May 2026 - 8:56
Quality of medicines: questions and answers - Part 2
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 16:32
Human medicines European public assessment report (EPAR): Adtralza, tralokinumab, Date of authorisation: 17/06/2021, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 16:30
Human medicines European public assessment report (EPAR): Pomalidomide Teva, pomalidomide, Date of authorisation: 14/11/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 16:14
Human medicines European public assessment report (EPAR): Camcevi, leuprorelin, Date of authorisation: 24/05/2022, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Status: Authorised
Submitted by Anonymous (not verified) on 28 May 2026 - 15:38
Human medicines European public assessment report (EPAR): Joenja, leniolisib, Date of authorisation: 21/05/2026, Status: Authorised
European Medicines Agency’s privacy statement for legal entity and bank account validation
Submitted by Anonymous (not verified) on 28 May 2026 - 15:30
European Medicines Agency’s privacy statement for legal entity and bank account validation
Data protection and privacy at EMA
Submitted by Anonymous (not verified) on 28 May 2026 - 15:30
Data protection and privacy at EMA
Champix
Submitted by Anonymous (not verified) on 28 May 2026 - 15:00
Champix